🔗 Share this article

While America undertakes sweeping revisions to its vaccine schedules, an unexpected name has emerged in a surprising turn: Tracy Beth Høeg, a US-based sports physician and epidemiologist who rose to prominence by expressing skepticism about COVID-19 vaccines in the global health crisis and has concentrated on potential deaths following COVID-19 immunization in her short position at the US Food and Drug Administration (FDA).

Proposed Shifts to Pediatric Vaccine Program

Health officials were set to reveal sweeping revisions to the pediatric vaccine schedule earlier this month, aligning the US with the Danish vaccine program, it is understood – a substantial departure that would put the US at odds with many the global community with little proof for benefit. The planned update has been pushed back until the next year.

Instead of the top vaccines chief, Tracy Beth Høeg is set to speak at the meeting. She was newly appointed acting director of the FDA’s CDER, the fifth appointee to head the division this calendar year.

Consolidating Power at the Regulatory Body

This interim role may indicate a tighter collaboration between the pharmaceutical and biologics centers as Dr. Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it points to a renewed priority upon rolling back long-standing immunizations at the FDA.

Høeg has repeatedly called for discontinuing certain pediatric immunization guidelines in the US so as to align more similar to Denmark's approach, a society with nationalized medicine and a population roughly the population of Wisconsin’s.

To date public appearances, she has persisted in emphasizing on vaccination policy – typically the purview of Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of medication approval.

Doubts Over Expertise

The appointee has no obvious track record in drug development, regulation or leadership, which has been customary for past directors of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a key advisor to the FDA chief and the vaccine center since spring.

“She doesn’t seem to have any of the qualifications” for overseeing the CDER, remarked Jonathan Howard. “She has not conducted a scientific study. She lacks experience in leading a large organization. She lacks background in pharmaceutical oversight.”

Past heads of the center would “understand laws and regulations and the underlying principles of medication creation”, said Dr. Janet Woodcock. “Clearly, she lacks the sort of resume that prior appointees who headed CBER have had.”

CDER has an enormous range of responsibilities at the agency, the former commissioner emphasized.

“Everybody just focuses on the innovative therapies, but the generic program authorizes a multitude of generic medications. There’s a biosimilars division, over-the-counter program and so forth, and all of those have to be supervised,” Dr. Woodcock said. “The thing you overlook, that’s the thing that I always told people is going to cause problems.”

There is also, a major leadership aspect to the position, which manages over 5,000 employees. “It’s a huge administrative position, if you perform it correctly,” the former official added.

Official Statement and Controversial Initiatives

Regarding concerns about Høeg’s credentials and whether this selection indicates increased cooperation among agency officials on vaccines, a spokesperson said that the “questions are based on incorrect premises”.

“Her experience aligns with the duties of her position,” the spokesperson stated, citing the time Høeg spent advising the FDA commissioner on “drug safety and approval science, including computational safety modeling and vaccine surveillance”.

As acting director, Høeg takes over the agency head's recently launched fast-track approval initiative, a controversial one-day drug-approval program that apparently troubled her predecessors. “How are these drugs being chosen for this expedited pathway? Who takes the calls?” Dr. Howard said. “There is a lot of lack of transparency happening at the regulatory body right now.”

Overall, he remarked, “the Food and Drug Administration looks to be trending towards laxer oversight of most medications, aside from immunizations.”

Established Past Work on Vaccines

With immunizations, Høeg has a more documented, if troubling, past, some experts said. She released a study using non-validated crowd-sourced reports to estimate the frequency of myocarditis following Covid vaccination. She counseled the Florida surgeon general Dr. Joseph Ladapo, who allegedly have changed statistics to imply Covid vaccinations are pose a greater threat than they are.

Included in her “desired changes” for the current government encompassed revising regulations for novel immunizations and ending “non-essential” immunizations, she said following the vote on a online show. At the agency, Dr. Høeg has allegedly floated the idea of barring adolescent males from obtaining COVID-19 vaccinations.

“She’s an all-around true believer who starts off with her conclusions and works backwards to retrofit the evidence in a extremely disingenuous, untruthful way,” Howard argued.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg became part of fellow contrarians, {like|